MetLife (MET) Projected to Post Earnings on Wednesday

Key Points

• MetLife will report Q1 2026 results after the close on Wednesday, May 6; analysts forecast $2.20 EPS and $19.29 billion in revenue, with a conference call set for May 7 at 9:00 AM ET.
• In the prior quarter (reported Feb. 4) MetLife beat estimates with $2.49 EPS and $52.44 billion in revenue (up 27.6% YoY), and analysts project roughly $10 EPS for the current fiscal year and $11 EPS next year.
• The stock has a market cap of about $51.06 billion and a P/E of 16.66; institutional investors own roughly 95% of shares and the consensus rating is "Moderate Buy" with a $93.38 price target.

MetLife (NYSE:MET - Get Free Report) is expected to announce its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of $2.20 per share and revenue of $19.2896 billion for the quarter. Investors can find conference call details on the company's upcoming Q1 2026 earning report page for the latest details on the call scheduled for Thursday, May 7, 2026 at 9:00 AM ET.

MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share for the quarter, beating the consensus estimate of $2.34 by $0.15. The business had revenue of $52.44 billion for the quarter, compared to the consensus estimate of $31.43 billion. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The business's quarterly revenue was up 27.6% compared to the same quarter last year. During the same quarter last year, the business posted $2.08 earnings per share. On average, analysts expect MetLife to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.

MetLife Stock Performance

NYSE MET opened at $78.30 on Wednesday. The company has a market cap of $51.06 billion, a PE ratio of 16.66, a price-to-earnings-growth ratio of 0.69 and a beta of 0.74. The stock's 50 day simple moving average is $73.10 and its 200-day simple moving average is $76.56. MetLife has a 1-year low of $67.33 and a 1-year high of $83.85. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20.

Hedge Funds Weigh In On MetLife

A number of institutional investors have recently added to or reduced their stakes in MET. AQR Capital Management LLC lifted its position in MetLife by 105.3% during the third quarter. AQR Capital Management LLC now owns 3,305,620 shares of the financial services provider's stock worth $271,424,000 after buying an additional 1,695,563 shares in the last quarter. Man Group plc raised its position in MetLife by 325.5% in the second quarter. Man Group plc now owns 1,344,551 shares of the financial services provider's stock valued at $108,129,000 after purchasing an additional 1,028,554 shares during the period. Zurich Insurance Group Ltd FI purchased a new stake in MetLife in the third quarter valued at $83,779,000. Deutsche Bank AG raised its position in MetLife by 47.9% in the fourth quarter. Deutsche Bank AG now owns 2,569,444 shares of the financial services provider's stock valued at $202,832,000 after purchasing an additional 831,986 shares during the period. Finally, Worldquant Millennium Advisors LLC raised its position in MetLife by 1,028.2% in the second quarter. Worldquant Millennium Advisors LLC now owns 856,905 shares of the financial services provider's stock valued at $68,912,000 after purchasing an additional 780,955 shares during the period. Hedge funds and other institutional investors own 94.99% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on MET shares. Mizuho decreased their target price on MetLife from $100.00 to $93.00 and set an "outperform" rating on the stock in a research report on Monday, April 13th. Morgan Stanley decreased their target price on MetLife from $101.00 to $93.00 and set an "overweight" rating on the stock in a research report on Tuesday, March 3rd. Wall Street Zen upgraded MetLife from a "hold" rating to a "buy" rating in a research report on Saturday, April 11th. Bank of America reduced their price objective on MetLife from $103.00 to $99.00 and set a "buy" rating on the stock in a research report on Tuesday, April 14th. Finally, Barclays reduced their price objective on MetLife from $92.00 to $89.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 8th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $93.38.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.